SynthesisFrontiers in oncology2022
CXCL5: A coachman to drive cancer progression.
Jie Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this papertrialcites it
SynthesisFrontiers in oncology2022
Jie Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.